Anastasia Budinskaya
Principal
NFX
Anastasia Budinskaya invests in TechBio platforms across women's health, longevity, and neurology as a Principal at NFX, where she leads and co-leads seed rounds with $2–6M checks. Her path from bioengineer and founder to investor spans clinical trials, corporate development, and the full arc of company building.
Sessions
-
23-Jun-202625ABCThe Billion-Dollar Frontier: Women’s Health as Smart Capital



